Back to main page

DREAM Module Identification Challenge – Consensus modules

PPI-STRING_Consensus_mod322

Assigned name NA
Network PPI-STRING
Module ID PPI-STRING_Consensus_mod322
Module size 82 genes

Module genes

This module comprises the following genes:

Gene ID Gene Symbol Gene Name
29123

ANKRD11 ankyrin repeat domain 11
23253

ANKRD12 ankyrin repeat domain 12
84164

ASCC2 activating signal cointegrator 1 complex subunit 2
80063

ATF7IP2 activating transcription factor 7 interacting protein 2
54971

BANP BTG3 associated nuclear protein
192197

BCAS3 breast carcinoma amplified sequence 3
7832

BTG2 BTG anti-proliferation factor 2
23523

CABIN1 calcineurin binding protein 1
865

CBFB core-binding factor subunit beta
64753

CCDC136 coiled-coil domain containing 136
159989

CCDC67 deuterosome assembly protein 1
55118

CEP68 cartilage acidic protein 1
1616

DAXX death domain associated protein
1761

DMRT1 doublesex and mab-3 related transcription factor 1
63946

DMRTC2 DMRT like family C2
133418

EMB embigin
2033

EP300 E1A binding protein p300
2118

ETV4 ETS variant 4
2274

FHL2 four and a half LIM domains 2
1647

GADD45A growth arrest and DNA damage inducible alpha
84253

GARNL3 GTPase activating Rap/RanGAP domain like 3
65056

GPBP1 GC-rich promoter binding protein 1
2874

GPS2 G protein pathway suppressor 2
100912262

GTF2I general transcription factor II-I repeat domain-containing protein 1-like
338328

HBP1 glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1
3159

HMGA1 high mobility group AT-hook 1
8091

HMGA2 high mobility group AT-hook 2
3150

HMGN1 high mobility group nucleosome binding domain 1
3151

HMGN2 high mobility group nucleosomal binding domain 2
9592

IER2 immediate early response 2
26145

IRF2BP1 interferon regulatory factor 2 binding protein 1
3713

IVL involucrin
133746

JMY junction mediating and regulatory protein, p53 cofactor
3725

JUN Jun proto-oncogene, AP-1 transcription factor subunit
55818

KDM3A lysine demethylase 3A
688

KLF5 Kruppel like factor 5
23641

LDOC1 LDOC1, regulator of NFKB signaling
79884

MAP9 microtubule associated protein 9
4149

MAX MYC associated factor X
57591

MKL1 myocardin related transcription factor A
57496

MKL2 myocardin related transcription factor B
4330

MN1 MN1 proto-oncogene, transcriptional regulator
4332

MNDA myeloid cell nuclear differentiation antigen
92140

MTDH metadherin
10608

MXD4 MAX dimerization protein 4
4609

MYC MYC proto-oncogene, bHLH transcription factor
80177

MYCT1 MYC target 1
93649

MYOCD myocardin
57447

NDRG2 NDRG family member 2
137814

NKX2-6 NK2 homeobox 6
26257

NKX2-8 NK2 homeobox 8
4824

NKX3-1 NK3 homeobox 1
26471

NUPR1 nuclear protein 1, transcriptional regulator
389493

NUPR1L nuclear protein 2, transcriptional regulator
401

PHOX2A paired like homeobox 2A
5570

PKIB cAMP-dependent protein kinase inhibitor beta
55269

PSPC1 paraspeckle component 1
295953

RAG2 recombination activating 2
10741

RBBP9 RB binding protein 9, serine hydrolase
56475

RPRM reprimo, TP53 dependent G2 arrest mediator homolog
861

RUNX1 runt related transcription factor 1
6278

S100A7 S100 calcium binding protein A7
29950

SERTAD1 SERTA domain containing 1
23411

SIRT1 sirtuin 1
54861

SNRK SNF related kinase
6660

SOX5 SRY-box 5
6667

SP1 Sp1 transcription factor
25803

SPDEF SAM pointed domain containing ETS transcription factor
6688

SPI1 Spi-1 proto-oncogene
153443

SRFBP1 serum response factor binding protein 1
6760

SS18 SS18, nBAF chromatin remodeling complex subunit
26039

SS18L1 SS18L1, nBAF chromatin remodeling complex subunit
6759

SSX4 SSX family member 4
55809

TRERF1 transcriptional regulating factor 1
10346

TRIM22 tripartite motif containing 22
23650

TRIM29 tripartite motif containing 29
51592

TRIM33 tripartite motif containing 33
29855

UBN1 ubinuclein 1
7350

UCP1 uncoupling protein 1
7392

USF2 upstream transcription factor 2, c-fos interacting
55249

YY1AP1 YY1 associated protein 1
6935

ZEB1 zinc finger E-box binding homeobox 1

Functional annotation

Modules were tested for enrichment in functional and pathway annotations using two complementary approaches:
1. To select a small number of specific / non-redundant annotations for each module, a regression-based approach was used;
2. To obtain the complete set of enriched annotations, an extension of Fisher’s exact test that takes annotation bias into account was employed (Wallenius’ non-central hypergeometric distribution).

Most specific annotations for this module

Coeff.1P-value.2Source.3Term.4Class.5
2.53e-01 5.48e-05 Reactome RUNX3 regulates RUNX1-mediated transcription

Gene expression (Transcription)
1.49e-01 1.53e-07 Reactome Formation of Senescence-Associated Heterochromatin Foci (SAHF)

Cellular responses to external stimuli
8.82e-02 1.64e-05 GO smooth muscle cell differentiation

biological_process
8.43e-02 1.24e-05 GO positive regulation of response to DNA damage stimulus

biological_process
7.53e-02 9.01e-06 GO positive regulation of cellular senescence

biological_process
5.87e-02 4.23e-06 Reactome RUNX3 regulates p14-ARF

Gene expression (Transcription)
4.87e-02 5.04e-04 GO negative regulation of cAMP-dependent protein kinase activity

biological_process
3.35e-02 5.00e-05 GO positive regulation by host of viral transcription

biological_process
2.86e-02 8.06e-04 GO response to UV-B

biological_process
2.64e-02 1.82e-04 Reactome RUNX1 regulates expression of components of tight junctions

Gene expression (Transcription)
2.64e-02 1.82e-04 Reactome RUNX1 regulates transcription of genes involved in interleukin signaling

Gene expression (Transcription)
1.91e-02 8.06e-04 GO ventricular cardiac muscle cell development

biological_process
1.87e-02 1.10e-06 GO protein-DNA complex

cellular_component
1.03e-02 1.28e-04 GO positive regulation of pri-miRNA transcription by RNA polymerase II

biological_process
8.00e-03 1.28e-04 GO R-SMAD binding

molecular_function
3.20e-03 8.10e-06 GO p53 binding

molecular_function
3.03e-03 1.65e-04 GO bHLH transcription factor binding

molecular_function
2.65e-03 4.14e-05 GO androgen receptor signaling pathway

biological_process
2.15e-03 3.45e-05 GO androgen receptor binding

molecular_function
8.70e-04 4.92e-05 GO E-box binding

molecular_function
8.06e-04 1.28e-04 GO nuclear hormone receptor binding

molecular_function

1Regression coefficient

2Fisher’s exact test nominal P-value

3Annotation source (Reactome, GO biological process (BP), molecular function (MF) and cellular component (CC))

4GO category or Reactome pathway

5High-level branch of annotation tree

Gene membership

All enriched annotations

Gene Ontology

P-value1 FDR2 Term
2.20e-09 1.10e-06 transcription cofactor activity

3.38e-09 1.65e-06 transcription factor activity, transcription factor binding

3.92e-09 1.90e-06 transcription factor activity, protein binding

5.68e-09 3.81e-06 transcription from RNA polymerase II promoter

3.22e-08 1.34e-05 transcription coactivator activity

7.81e-08 3.05e-05 RNA polymerase II transcription factor activity, sequence-specific DNA binding

1.47e-07 4.84e-05 chromatin

6.44e-07 3.18e-04 negative regulation of transcription from RNA polymerase II promoter

2.09e-06 6.24e-04 transcription regulatory region DNA binding

2.12e-06 6.33e-04 regulatory region DNA binding

3.27e-06 9.41e-04 core promoter binding

4.25e-06 1.20e-03 transcription factor binding

6.61e-06 2.66e-03 chromatin organization

1.98e-05 4.88e-03 double-stranded DNA binding

2.12e-05 4.87e-03 nuclear body

3.36e-05 1.13e-02 positive regulation of cellular senescence

4.20e-05 9.68e-03 transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding

4.67e-05 1.51e-02 covalent chromatin modification

5.22e-05 1.67e-02 positive regulation of cell aging

6.66e-05 1.45e-02 transcription regulatory region sequence-specific DNA binding


11Nominal enrichment p-value (Wallenius’ noncentral hypergeometric distribution)

2FDR corrected p-value (Benjamini-Hochberg)

Reactome

P-value1 FDR2 Term
8.28e-05 1.07e-02 TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER
3.23e-04 3.66e-02 SIGNALING BY TGF BETA RECEPTOR COMPLEX
8.10e-04 9.79e-02 TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER
1.05e-03 1.05e-01 PRE NOTCH TRANSCRIPTION AND TRANSLATION
1.28e-03 1.25e-01 SIGNALING BY NOTCH
1.63e-03 1.55e-01 SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION
3.01e-03 3.02e-01 SIGNALING BY TGF BETA RECEPTOR COMPLEX
3.31e-03 2.89e-01 PRE NOTCH EXPRESSION AND PROCESSING
3.93e-03 3.34e-01 NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION
6.62e-03 5.75e-01 PRE NOTCH TRANSCRIPTION AND TRANSLATION
7.53e-03 6.38e-01 SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION
9.31e-03 7.56e-01 SIGNALING BY NOTCH
1.00e-02 7.32e-01 TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION
1.01e-02 7.38e-01 SIGNALING BY NOTCH1
1.37e-02 1.00e+00 PRE NOTCH EXPRESSION AND PROCESSING
1.44e-02 9.84e-01 INTEGRATION OF PROVIRUS
1.56e-02 1.00e+00 NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION
1.60e-02 1.00e+00 APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION
1.68e-02 1.00e+00 APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION
1.72e-02 1.00e+00 PPARA ACTIVATES GENE EXPRESSION

11Nominal enrichment p-value (Wallenius’ noncentral hypergeometric distribution)

2FDR corrected p-value (Benjamini-Hochberg)

Mouse mutant phenotypes

P-value1 FDR2 Term
1.38e-04 2.81e-01 increased fibroblast proliferation

1.78e-04 3.25e-01 internal hemorrhage

2.91e-04 4.41e-01 palate bone hypoplasia

7.77e-04 7.77e-01 decreased Paneth cell number

1.78e-03 1.00e+00 increased sensitivity to skin irradiation

2.11e-03 1.00e+00 increased T cell derived lymphoma incidence

3.57e-03 1.00e+00 decreased thymocyte number

3.66e-03 1.00e+00 abnormal T cell subpopulation ratio

3.72e-03 1.00e+00 abnormal testis development

3.82e-03 1.00e+00 hemoperitoneum

3.97e-03 1.00e+00 abnormal lymph organ development

3.99e-03 1.00e+00 lymph node hypoplasia

4.23e-03 1.00e+00 decreased CD8-positive, alpha-beta T cell number

4.23e-03 1.00e+00 abnormal chromosome number

4.24e-03 1.00e+00 abnormal leukopoiesis

4.27e-03 1.00e+00 pale yolk sac

4.32e-03 1.00e+00 abnormal inguinal fat pad morphology

5.02e-03 1.00e+00 exencephaly

5.08e-03 1.00e+00 absent mature B cells

5.37e-03 1.00e+00 decreased erythroid progenitor cell number


11Nominal enrichment p-value (Wallenius’ noncentral hypergeometric distribution)

2FDR corrected p-value (Benjamini-Hochberg)


Generated on: Thu Aug 30 17:35:37 2018 - R2HTML